Holtec Nuclear is marketing one of the largest U.S. energy IPOs of 2026. The prospectus does not describe a single clean business. It combines established spent-fuel and nuclear-services operations, an 800-megawatt reactor restart, and a small-modular-reactor plan that is still years from commercial operation.
As of September 9, 2026 | Photo by Lukáš Lehotský on Unsplash
HNUC is a services business carrying two large development bets
The mature nuclear-services franchise gives Holtec something most advanced-reactor stories lack: current revenue and customers. Palisades and the SMR-300 create the larger upside narrative, but they also make the economics harder to read. The public shares add a third complication through an UP-C structure, founder voting control and a tax-receivable agreement.
Holtec said on September 8 that it is offering 50 million Class A shares at an expected price of $15 to $18, with an underwriter option for another 7.5 million shares. Reuters reported that the high end would value the company at about $10.2 billion and raise as much as $900 million before fees. The proposed Nasdaq symbol is HNUC.
Those offering terms are current. The deeper business record comes from Holtec’s July Form S-1, which still contains blanks where the final share count, pricing and ownership percentages will eventually appear. That matters. The roadshow has started, but the final prospectus and allocation have not been set.
The share count and price range are announced offering terms, not a completed sale. Historical and pro forma figures come from the SEC prospectus. Palisades timing, SMR costs, margins and deployment dates are management plans or projections unless described otherwise. None of them is a promise.
The first layer: a real nuclear-services franchise
Holtec’s Nuclear Power Division is the company’s largest and most mature segment. It designs and supplies systems for spent-fuel storage and transport, heat-transfer equipment, plant services and decommissioning work. The filing says dry storage produces the majority of divisional revenue. Initial storage programs can run from roughly $40 million to more than $400 million per plant, followed by recurring equipment and loading orders.
This is the part of Holtec that should anchor the analysis. It serves more than 150 commercial reactors, sells engineered equipment into a regulated industry and enters multiyear contracts. It is not a speculative reactor developer with no operating base.
The financial statements still require care. Historical 2025 revenue was $576.6 million, down from $765.5 million in 2024. Operating income fell to $37.1 million from $291.0 million. Reported net income was much higher at $386.6 million, but net other income contributed $433.9 million. That included $230.0 million of unrealized investment gains and $118.5 million of realized gains, much of it tied to nuclear decommissioning trusts.
The proposed restructuring changes the picture again. Holtec presents pro forma 2025 revenue of $893.4 million and gross operating profit of $290.7 million after giving effect to the NAMCO transactions. It also states a pro forma backlog above $5.2 billion over the next ten years. Backlog is signed expected revenue, not guaranteed sales. Customer cancellations, schedule changes, financing and regulatory milestones can all delay conversion.
The second layer: Palisades is closer, but not finished
Holtec is trying to return the 800 MW Palisades plant in Michigan to commercial operation after its 2022 shutdown. The SEC filing says the plant moved from decommissioning status to operating status for regulatory purposes in August 2025, following NRC approval of the licensing package. It was authorized to receive fuel and continue restart preparations. Final power operations still depend on technical specifications and regulatory requirements.
The funding and revenue framework are substantial. The U.S. Department of Energy closed a loan of up to $1.52 billion for the project, and Michigan committed a $300 million grant. Holtec also has long-term power purchase agreements with Wolverine Power Supply Cooperative and Hoosier Energy. The buyers agreed to take the plant’s output under fixed-price arrangements, subject to the contract terms.
No Palisades electricity revenue was recognized in 2025 because the plant was not operating. That line is important. A long contract does not produce cash until the reactor produces and delivers electricity. Restart timing, remaining testing, cost control and reliable operation are the next proof points.
What remains an execution claim: commercial operation in 2026 and the plant’s realized economics after restart.
The third layer: SMR-300 is optionality, not current earnings
Holtec’s SMR-300 is a pressurized-water small modular reactor. The company targets commercial operation of its first dual-unit project at Palisades in the early 2030s. It projects a revenue opportunity of $2.0 billion to $2.5 billion for the sale of a dual-unit plant, with a targeted gross margin of 25% to 35%. It also targets overnight capital costs of $7,500 to $8,500 per kilowatt in higher-cost markets.
Those are management projections. The filing states that Holtec has not constructed an SMR-300, secured all necessary regulatory approvals or entered definitive customer agreements for delivery or power offtake from an SMR-300. Several international opportunities are memoranda of understanding. They may never become contracts.
The UK regulatory record is useful precisely because it is limited. British regulators completed Step 2 of the SMR-300 generic design assessment in March 2026. The government says the process did not proceed to the detailed Step 3, and any project would still need site-specific permissions. That is progress, not commercial approval.
The right way to treat the SMR-300 is as a milestone chain: detailed licensing, financing, firm offtake, first-of-a-kind construction, commissioning and repeat orders. Revenue forecasts several years out cannot replace those steps.
The fourth layer: public shareholders buy a minority economic position
Holtec uses an umbrella partnership C-corporation, or UP-C, structure. After the reorganization, the public corporation will control Holtec International as managing member, but public Class A shareholders will initially hold a minority economic interest. Holtec Holdings and related legacy owners retain Class B interests in the operating company.
The voting structure is more concentrated. Class B shares carry ten votes each until a sunset tied to ownership falls below a stated threshold. The filing says the sunset is not automatically triggered by the founder’s death or intra-family transfers. Holtec Holdings will continue to control a majority of the combined vote after the offering.
There is also a tax receivable agreement. Holtec Nuclear expects to pay beneficiaries 85% of certain cash tax savings it is deemed to realize from basis increases, exchanges and related tax attributes. These arrangements are common in some founder-led IPOs, but they shift part of future tax benefits away from public shareholders.
The use of proceeds deserves attention when the amended prospectus arrives. The July filing says proceeds will purchase interests in the operating company, support distributions to existing holding entities and fund general corporate purposes that may include SMR licensing and manufacturing. Dollar amounts remain blank in that version.
| Layer | Evidence today | Main uncertainty | Next useful milestone |
|---|---|---|---|
| Nuclear Power Division | Current revenue, customers, recurring storage orders and contracted backlog | Revenue variability, backlog timing and restructuring comparability | Post-IPO segment revenue, operating margin and cash conversion |
| Palisades | Regulatory transition, public financing and long-term PPAs | Final restart work, timing, operating reliability and cost | Commercial power production and reported plant economics |
| SMR-300 | Design work, suppliers, early regulatory reviews and project pipeline | No operating unit, final approvals or firm delivery base | Detailed license progress, financing and binding offtake |
| Class A shares | Economic participation in the controlled operating company | Founder voting control, exchange rights and tax payments | Final prospectus ownership, dilution and use-of-proceeds tables |
What does the reported valuation assume?
Reuters’ reported $10.2 billion high-end valuation is roughly 11 times Holtec’s $893.4 million pro forma 2025 revenue. That is a blunt comparison, not a valuation verdict. The revenue figure includes restructuring adjustments, while the equity value reflects expectations for a restarted power plant and an advanced-reactor platform that are not yet fully earning.
The conclusion is still useful. Buyers at the high end would not be paying only for a mature dry-storage supplier. They would be underwriting successful Palisades operation, improved earnings visibility and meaningful SMR progress. Current services revenue provides credibility. It does not remove project risk.
Five checks before the final prospectus
- Final ownership and voting percentages: the July filing leaves them blank. These numbers determine the public float and the strength of founder control.
- Net proceeds and distributions: gross proceeds are not cash retained for growth. Underwriting costs, purchases of operating interests and distributions must be separated.
- Pro forma operating cash flow: trust investment gains and asset-retirement accounting can make net income look stronger than the industrial business.
- Palisades commercial operation: first electricity sales would convert a long-duration PPA from backlog into reported revenue.
- Binding SMR milestones: signed offtake, financing and detailed regulatory approvals matter more than the size of an announced opportunity pipeline.
Not a pure SMR stock, and not a simple industrial IPO
Holtec brings something rare to the advanced-nuclear market: an operating services franchise with customers, revenue and a long contract base. That makes HNUC more grounded than a development-only reactor story.
The complication is structural, not cosmetic. Historical profit is distorted by trust investments and decommissioning accounting. Palisades has financing and contracts but had not produced power in the reported period. The SMR-300 remains pre-deployment. Public investors would also accept minority economics under concentrated voting control.
The final prospectus should be read as a bridge between three businesses at different stages of proof. The services franchise is the foundation. Palisades is the near-term test. SMR-300 is long-duration optionality. Blurring them produces the wrong investment question.
For broader context, see the Market Radar archive, our comparison of nuclear stocks with contracted AI data-center exposure, and the guide to how dilution affects shareholders.
Sources
- Holtec Nuclear Corporation: IPO launch and marketed terms, September 8, 2026.
- Holtec Nuclear Corporation Form S-1 registration statement, filed July 10, 2026.
- U.S. Department of Energy: Palisades loan project overview.
- U.S. Department of Energy: Palisades loan disbursement, March 18, 2025.
- UK Office for Nuclear Regulation and Environment Agency: SMR-300 Step 2 assessment, March 31, 2026.
- Reuters: Holtec’s marketed valuation and IPO context, September 8, 2026.
Editorial disclosure: This article separates reported financial results, announced offering terms, government support, company projections and MarketInsiderLab analysis. Holtec’s marketed range can change before pricing.
Investment disclosure: This material is for general informational and educational purposes. It is not personalized investment advice, a recommendation to buy or sell any security, or a promise of future performance. IPOs and public-market investments can lose value. Review the final prospectus and consider your own objectives and risk tolerance.